167 studies found for:    alps
Show Display Options
Download search resultsDownload the search results for:
alps (167 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed
Has Results
Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)
Conditions: ALPS;   Hypersplenism;   Lymphadenopathy
Interventions: Drug: Valproic Acid;   Procedure: CT Scan;   Procedure: Blood Sample
2 Recruiting Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Conditions: Autoimmune Disease;   Lymphatic Disease;   Lymphoproliferative Disorder;   Canale-Smith Syndrome
Intervention:
3 Recruiting Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Conditions: Pregnancy;   Respiratory Distress;   Pregnancy Outcome
Intervention: Drug: Corticosteroid
4 Completed Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
Conditions: Lymphoproliferative Disorders;   Lymphoma
Intervention:
5 Completed Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome
Conditions: Autoimmune Disease;   Lymphatic Disease;   Lymphoproliferative Disorder
Intervention: Drug: Pyrimethamine
6 Completed Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome
Conditions: Autoimmune Disease;   Lymphoproliferative Disorder
Intervention: Drug: Fansidar (pyrimethamine and sulfadoxine)
7 Recruiting Fluorodeoxyglucose Imaging Studies to Detect Lymphoma
Conditions: Autoimmune Lymphoproliferative Syndrome;   Lymphoma
Intervention:
8 Recruiting Sirolimus for Autoimmune Disease of Blood Cells
Conditions: Autoimmune Pancytopenia;   Autoimmune Lymphoproliferative Syndrome (ALPS);   Evans Syndrome;   Idiopathic Thrombocytopenic Purpura;   Anemia, Hemolytic, Autoimmune;   Autoimmune Neutropenia;   Lupus Erythematosus, Systemic;   Inflammatory Bowel Disease;   Rheumatoid Arthritis
Intervention: Drug: sirolimus
9 Completed
Has Results
Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs
Condition: Cancer
Intervention: Drug: Tyrosine kinase inhibitors
10 Completed How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)?
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Other: High sugar low starch diet;   Other: Low sugar high starch diet
11 Unknown  Asthma Learning Project
Condition: Asthma
Interventions: Other: Educational game;   Other: Educational game + motivational interview;   Other: Motivational interview
12 Completed Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)
Conditions: Hypertension;   Coronary Atherosclerosis
Intervention: Drug: Calcium channel blockers (amlodipine, azelnidipine)
13 Completed
Has Results
Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Abatacept;   Drug: Placebo;   Drug: Prednisone
14 Completed
Has Results
A Human Trial to Evaluate the Efficacy and Safety of Fermented Turmeric in Subjects Showing Mild Hepatic Injury
Condition: Mild Hepatic Injury
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Fermented turmeric
15 Recruiting FG-4592 (ASP1517) in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis
Condition: Anemia in Chronic Kidney Disease in Non-dialysis Patients
Interventions: Drug: FG-4592;   Drug: Placebo
16 Recruiting Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Condition: Cardiac Arrest
Interventions: Drug: amiodarone;   Drug: Lidocaine;   Other: Normal saline
17 Active, not recruiting Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2
Condition: Type 1 Diabetes
Interventions: Drug: Alprazolam;   Drug: Placebo
18 Completed
Has Results
A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases
Conditions: Hormone Refractory Prostate Cancer;   Bone Metastases
Interventions: Drug: Radium-223 dichloride (Xofigo, BAY88-8223);   Drug: Placebo;   Drug: Best standard of care (BSoC)
19 Completed Genetic Mapping of Atherogenic Lipoprotein Phenotypes
Conditions: Atherosclerosis;   Cardiovascular Diseases;   Heart Diseases
Intervention:
20 Completed Effects of Topical SLPI on Skin Wounds
Conditions: Healthy;   Wound Healing
Intervention: Drug: SLPI (Secretory Leukocyte Protease Inhibitor)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years